Show simple item record

Vasoactive Intestinal Peptide Receptors in Human Platelet Membrane. Characterization of Binding and Functional Activity

dc.contributor.authorErcal, N.en_US
dc.contributor.authorO'Dorisio, M. S.en_US
dc.contributor.authorVinik, Aaron I.en_US
dc.contributor.authorO'Dorisio, T. M.en_US
dc.contributor.authorKadrofske, Mark M.en_US
dc.date.accessioned2010-06-01T19:58:02Z
dc.date.available2010-06-01T19:58:02Z
dc.date.issued1988-06en_US
dc.identifier.citationERCAL, N.; O'DORISIO, M. S.; VINIK, A.; O'DORISIO, T. M.; KADROFSKE, M. (1988). "Vasoactive Intestinal Peptide Receptors in Human Platelet Membrane. Characterization of Binding and Functional Activity." Annals of the New York Academy of Sciences 527(1 Vasoactive Intestinal Peptide and Related Peptides ): 663-666. <http://hdl.handle.net/2027.42/73096>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73096
dc.format.extent161913 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights1988 The New York Academy of Sciencesen_US
dc.titleVasoactive Intestinal Peptide Receptors in Human Platelet Membrane. Characterization of Binding and Functional Activityen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Physiology, Pediatrics, and Medicine The Ohio State University Columbus, Ohio 43210 and Department of Medicine University of Michigan Ann Arbor, Michiganen_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73096/1/j.1749-6632.1988.tb27036.x.pdf
dc.identifier.doi10.1111/j.1749-6632.1988.tb27036.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceCox, C. P., J. Linden & S. I. Said. 1984. VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). Peptides 5: 325 – 328.en_US
dc.identifier.citedreferenceBaenziger, N. L. & P. W. Majerus. 1974. Isolation of human platelets and platelet surface membranes. Methods Enzymol. 31: 149.en_US
dc.identifier.citedreferenceO'Dorisio, M. S., T. M. O'Dorisio, C. L. Wood, J. C. Bresnahan, M. S. Beattie & L. B. Campolito. 1988. Characterization of vasoactive intestinal peptide receptors in nervous and immune systems. Ann. N.Y. Acad. Sci. This volume.en_US
dc.identifier.citedreferenceAkera, T. & V. J. K. Cheng. 1977. A simple method for the determination of affinity and binding site concentration in receptor binding studies. Biochem. Biophys. Acta 470: 412 – 423.en_US
dc.identifier.citedreferenceFarr, R. S., C. P. Cox, M. L. Wordlow & R. Jorgensen. 1980. Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF). Clin. Immunol. Immunopathol. 15: 318 – 330.en_US
dc.identifier.citedreferenceChignard, M., J. P. Le Couedic, M. Tence, B. B. Vargaftig & J. Beneviste. 1979. The role of platelet activating factor in platelet aggregation. Nature (London) 279: 799 – 800.en_US
dc.identifier.citedreferenceHaslam, R. J. & M. Vanderwell. 1982. Inhibition of platelet adenylate cyclase by 1-0-alkyl-2-0-acetyl-sn-glycerl-3-phosphorylcholine (PAF). J. Biol. Chem. 257: 6879 – 6885.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.